Personal information

No personal information available

Activities

Collapse all

Works (4)

Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions

British Journal of Clinical Pharmacology
2021-04 | Journal article
DOI: 10.1111/bcp.14576
Contributors: Xu‐Ben Yu; Zheng Jiao; Chun‐Hong Zhang; Ying Dai; Zi‐Ye Zhou; Lu Han; Xin Wen; Chang‐Cheng Sheng; Guan‐Yang Lin; Jing‐Ye Pan
Source: check_circle
Crossref

Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy

2020-07-02 | Preprint
DOI: 10.1101/2020.06.30.180117
Contributors: Chen-yu Wang; Chang-cheng Sheng; Guang-li Ma; Da Xu; Xiao-qin Liu; Yu-ya Wang; Li Zhang; Chuan-liang Cui; Bing-he Xu; Yu-qin Song et al.
Source: check_circle
Crossref

Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co‐administered with tacrolimus

British Journal of Clinical Pharmacology
2019-04 | Journal article
DOI: 10.1111/bcp.13850
Contributors: Huan‐Xi Zhang; Chang‐Cheng Sheng; Long‐Shan Liu; Bi Luo; Qian Fu; Qun Zhao; Jun Li; Yan‐Feng Liu; Rong‐Hai Deng; Zheng Jiao et al.
Source: check_circle
Crossref

Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients

Clin Chim Acta
2018-06-28 | Journal article
Source: Self-asserted source
Chang-Cheng SHENG
How many people are using ORCID?